Company registration number 11271502 (England and Wales)
WEST OPHTHALMOLOGY LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
WEST OPHTHALMOLOGY LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 6
WEST OPHTHALMOLOGY LIMITED
BALANCE SHEET
AS AT 31 MARCH 2025
31 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
3
1,090
1,504
Investments
4
451,931
363,840
453,021
365,344
Current assets
Debtors
5
19,730
19,442
Cash at bank and in hand
367,421
350,082
387,151
369,524
Creditors: amounts falling due within one year
6
(34,696)
(46,760)
Net current assets
352,455
322,764
Total assets less current liabilities
805,476
688,108
Provisions for liabilities
(8,239)
(7,159)
Net assets
797,237
680,949
Capital and reserves
Called up share capital
100
100
Non-distributable profits reserve
7
23,900
20,347
Distributable profit and loss reserves
773,237
660,502
Total equity
797,237
680,949
WEST OPHTHALMOLOGY LIMITED
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2025
31 March 2025
- 2 -

For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 13 October 2025 and are signed on its behalf by:
Dr M Smith
Dr E Frayn
Director
Director
Company registration number 11271502 (England and Wales)
WEST OPHTHALMOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 3 -
1
Accounting policies
Company information

West Ophthalmology Limited is a private company limited by shares incorporated in England and Wales. The registered office is The Summit, Woodwater Park, Pynes Hill, Exeter, United Kingdom, EX2 5WS.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of discounts.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost, net of depreciation.

Depreciation is recognised so as to write off the cost of assets less their residual values over their useful lives on the following bases:

Plant and equipment
25% per annum on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Fixed asset investments

Investments held are measured at fair value through the profit and loss with reference to readily available market values of the investments owned. The change in fair value is recorded in the company profit and loss and any gain (after allowing for deferred tax) is credited to non-distributable reserves.

1.5
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

WEST OPHTHALMOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 4 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
2
3
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 April 2024 and 31 March 2025
1,655
Depreciation and impairment
At 1 April 2024
151
Depreciation charged in the year
414
At 31 March 2025
565
Carrying amount
At 31 March 2025
1,090
At 31 March 2024
1,504
4
Fixed asset investments
2025
2024
£
£
Other investments other than loans
451,931
363,840
Fixed asset investments revalued

Fixed asset investments are revalued to market value each year in line with the investment portfolio manager's reports. The book value of these investments at 31 March 2025 was £420,064 (2024: £336,710).

WEST OPHTHALMOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
4
Fixed asset investments
(Continued)
- 5 -
Movements in fixed asset investments
Investments
£
Cost or valuation
At 1 April 2024
363,840
Additions
75,000
Valuation changes
4,737
Reinvested units
10,847
Realised surplus on disposal
589
Disposals
(3,082)
At 31 March 2025
451,931
Carrying amount
At 31 March 2025
451,931
At 31 March 2024
363,840
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
1,734
7,409
Other debtors
17,996
12,033
19,730
19,442
6
Creditors: amounts falling due within one year
Restated
2025
2024
£
£
Trade creditors
274
261
Taxation and social security
32,399
37,450
Other creditors
2,023
9,049
34,696
46,760
WEST OPHTHALMOLOGY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 6 -
7
Non-distributable profits reserve
2025
2024
£
£
At the beginning of the year
20,347
8,900
Non distributable profits in the year
3,553
11,447
At the end of the year
23,900
20,347
8
Directors' transactions

Advances or credits have been granted by the company to its directors as follows:

Description
% Rate
Opening balance
Amounts advanced
Amounts repaid
Closing balance
£
£
£
£
Directors loan account
2.25
(594)
5,883
(3,311)
1,978
(594)
5,883
(3,311)
1,978

The aforementioned advances are unsecured and repayable on demand.

2025-03-31 2024-04-01 false false false 13 October 2025 CCH Software CCH Accounts Production 2025.300 No description of principal activity Mr M Smith Dr E Frayn 11271502 2024-04-01 2025-03-31 11271502 2025-03-31 11271502 2024-03-31 11271502 core:OtherPropertyPlantEquipment 2025-03-31 11271502 core:OtherPropertyPlantEquipment 2024-03-31 11271502 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 11271502 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 11271502 core:WithinOneYear 2025-03-31 11271502 core:WithinOneYear 2024-03-31 11271502 core:ShareCapital 2025-03-31 11271502 core:ShareCapital 2024-03-31 11271502 core:FurtherSpecificReserve1ComponentTotalEquity 2025-03-31 11271502 core:FurtherSpecificReserve1ComponentTotalEquity 2024-03-31 11271502 core:RetainedEarningsAccumulatedLosses 2025-03-31 11271502 core:RetainedEarningsAccumulatedLosses 2024-03-31 11271502 bus:Director1 2024-04-01 2025-03-31 11271502 bus:Director2 2024-04-01 2025-03-31 11271502 core:PlantMachinery 2024-04-01 2025-03-31 11271502 2023-04-01 2024-03-31 11271502 core:OtherPropertyPlantEquipment 2024-03-31 11271502 core:OtherPropertyPlantEquipment 2024-04-01 2025-03-31 11271502 core:CurrentFinancialInstruments 2025-03-31 11271502 core:CurrentFinancialInstruments 2024-03-31 11271502 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 11271502 bus:FRS102 2024-04-01 2025-03-31 11271502 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 11271502 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 11271502 bus:FullAccounts 2024-04-01 2025-03-31 xbrli:pure xbrli:shares iso4217:GBP